Company intelligence / Profile preview

IMGM Laboratories

Martinsried, Bavaria, Germany

Ownership: Private
Employees: ~35
Development stage: Other

Overview

IMGM Laboratories is a specialized Contract Research Organization (CRO) based in Martinsried, Germany, providing advanced genomic services to the pharmaceutical, diagnostics, and academic sectors. The company offers a comprehensive portfolio including Next-Generation Sequencing (NGS), qPCR, digital PCR, and sophisticated bioinformatics analysis. IMGM is recognized for its high-quality standards, holding ISO 17025 accreditation and offering GLP-compliant services for clinical trials and biomarker discovery. In 2022, the company was acquired by Medicover to enhance its genetics and diagnostic capabilities, integrating its expertise into a broader international healthcare network.

Industry: Contract Research Organization

Partnerships

RocheIlluminaPacific Biosciences10x Genomics

Beyond the preview

Go deeper on IMGM Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMGM Laboratories.

Explore the full profile